VRAY
|
ViewRay, Inc.
|
0.01%
|
US
|
NASDAQ
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
0.01%
|
US
|
NASDAQ
|
VERV
|
Verve Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
TSVT
|
2seventy bio, Inc.
|
0.01%
|
US
|
NASDAQ
|
TMCI
|
Treace Medical Concepts, Inc.
|
0.01%
|
US
|
NASDAQ
|
TBPH
|
Theravance Biopharma, Inc.
|
0.01%
|
US
|
NASDAQ
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
SRNE
|
Sorrento Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
SRDX
|
SurModics, Inc.
|
0.01%
|
US
|
NASDAQ
|
SIGA
|
SIGA Technologies Inc.
|
0.01%
|
US
|
NASDAQ
|
SIBN
|
SI-BONE, Inc.
|
0.01%
|
US
|
NASDAQ
|
SGMO
|
Sangamo BioSciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
SENS
|
Senseonics Holdings, Inc.
|
0.01%
|
US
|
AMEX
|
SANA
|
Sana Biotechnology, Inc.
|
0.01%
|
US
|
NASDAQ
|
RXRX
|
Recursion Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
RXDX
|
Prometheus Biosciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
RGNX
|
REGENXBIO Inc.
|
0.01%
|
US
|
NASDAQ
|
REPL
|
Replimune Group, Inc.
|
0.01%
|
US
|
NASDAQ
|
RAPT
|
RAPT Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
QTRX
|
Quanterix Corporation
|
0.01%
|
US
|
NASDAQ
|